Company Filing History:
Years Active: 2014-2017
Title: **The Innovations of Thorsten M. Schlaeger: A Pioneer in Cell Reprogramming**
Introduction
Thorsten M. Schlaeger is an influential inventor based in Brookline, Massachusetts, known for his significant contributions to the field of cellular biology and biotechnology. With two innovative patents to his name, he has made strides in understanding human somatic cell reprogramming, which holds promise for advancements in regenerative medicine.
Latest Patents
Schlaeger’s most recent patents focus on the detection of human somatic cell reprogramming. His methods and kits are rooted in the discovery of a specific phenotype indicating a fully-reprogrammed induced pluripotent stem (iPS) cell along with various reprogramming intermediates. The innovative techniques allow for the identification of fully-reprogrammed iPS cells and enable the monitoring of iPS cell emergence throughout the reprogramming process. These methods can be executed in real-time using live cell imaging, thereby representing a significant advancement in the biotechnology sector. Additionally, Schlaeger has developed methods for screening candidate reprogramming agents by observing the emergence of fully-reprogrammed iPS cells in varying conditions.
Career Highlights
Thorsten M. Schlaeger serves at Children's Medical Center Corporation, where his research and inventions are paving the way for more effective and efficient therapeutic techniques in regenerative medicine. His work not only underscores the importance of innovation in medical research but also illustrates the potential impact of his inventions on future clinical applications.
Collaborations
Throughout his career, Schlaeger has collaborated with esteemed colleagues such as George Q. Daley and In-Hyun Park. These partnerships are reflections of a collaborative spirit in scientific research, indicating a shared commitment to advancing knowledge in the field of cell reprogramming and regenerative medicine.
Conclusion
Thorsten M. Schlaeger’s work exemplifies the intersection of innovation and biomedical research. His patents in the detection of cell reprogramming reveal significant advancements that may greatly influence the future of individualized therapies. As the field of regenerative medicine continues to evolve, inventors like Schlaeger will undoubtedly play a critical role in shaping its trajectory.